Merck & Co., Inc. (NYSE:MRK) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...
The Highland County Press7h
FDA approves novel non-opioid treatment for moderate to severe acute pain
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx ...
Gulfbusiness.com on MSN23h
Mega wellbeing resort, interactive park to come up in Dubai
Dubai has unveiled plans to develop ‘Therme Dubai,’ a first-of-its-kind wellbeing resort and interactive park in the region, ...
Malaysian Reserve18h
Liva Healthcare acquires Momenta, and secures funding from new and existing investors to drive growth
Purchase of UK-based Discover Momenta and Momenta Newcastle ('Momenta') for undisclosed amountAcquisition will significantly increase Liva's reach and ...